Corey Schuler, PhD, FNP, CNS
It is not always obvious whether a patient’s symptoms reflect glandular failure, substrate mismanagement, or an organism shifting into conservation under sustained energetic strain. Thyroid labs may drift upward. Triglycerides may rise. Motivation may soften. Glucose values can appear pristine, even as metabolic volatility hides beneath the surface.
The following case illustrates a scenario in which a patient presents with “normal labs,” yet demonstrates a conservation‑dominant allocation pattern under sustained energetic strain [1]. In this context, treating a single laboratory value would have missed the underlying architecture entirely.
Patient Presentation
A 42‑year‑old woman presents with a constellation of concerns that developed gradually over the prior year. She reports a 15‑pound weight gain, persistent morning and late‑afternoon fatigue, and a noticeable loss of motivation accompanied by mild cognitive “fog.” Despite maintaining an active lifestyle, she describes poor recovery from strenuous exercise. She also notes moderate‑to‑high perceived stress, frequent night sweats, and a tendency to sleep hot.
She attributes many of these changes to aging, but wonders whether they could reflect perimenopause, cortisol dysregulation, or blood sugar instability.
Laboratory Findings
Initial laboratory evaluation shows thyroid and glycemic markers within conventional reference ranges:
- Thyroid-stimulating hormone (TSH): 2.79 mU/L (up from 1.6 one year prior)
- Free thyroxine (T4): 1.0 ng/dL
- Free triiodothyronine (T3): 3.0 pg/mL
- Reverse T3: 15 ng/dL
- Fasting glucose: 93 mg/dL
- Hemoglobin A1c (HbA1c): 4.9%
- Fasting insulin: 7.8 µIU/mL
Based on these findings, she was reassured that her thyroid and blood sugar markers were “normal.”
Additional data, however, complicated that conclusion. Her vitamin D level was low at 23 ng/mL, and her triglycerides were markedly elevated at 280 mg/dL, elevated total cholesterol at 254 mg/dL and low HDL cholesterol at 42 mg/dL. A continuous glucose monitor, implemented on her own initiative, revealed that she spent 38% of her time below range, despite a normal A1c.
The Temptation: “Subclinical Hypothyroidism”
At first glance, attention is naturally drawn to the TSH, as it has risen compared to prior measurements. A clinician focused narrowly on thyroid physiology might be tempted to label this as evolving subclinical hypothyroidism and consider low‑dose exogenous thyroid hormone replacement.
But this is not primarily a thyroid case. While the hypothalamic-pituitary-thyroid (HPT) axis is involved, its behavior may reflect something different. Rather than signaling glandular dysfunction, it may be providing metabolic pacing as a protective mechanism. [1]
Free T4 and free T3 remain within range, and reverse T3 is not elevated. The thyroid axis appears to be compensating rather than collapsing. The TSH drift is a signal but not necessarily a mandate for hormone replacement. The thyroid may not be the prime mover here, even though the symptoms sound thyroid‑like.
The Pattern: Conservation Under Strain
Viewed through an Energy Allocation System lens, this presentation is more consistent with a conservation‑dominant allocation pattern under sustained energetic strain. [1] This pattern is typically characterized by:
- Increased energetic caution
- Blunted motivational drive
- Reduced recovery capacity
- Substrate inefficiency
- Gradual metabolic deceleration [1]
The body is not failing. It is hedging. While labeling her labs as “normal” is technically correct, it often leads to a frustrating “watch and wait” posture that leaves patients feeling unseen and discouraged.
The Clues Are Metabolic, Not Glycemic
Her fasting glucose, HbA1c, and even insulin are unremarkable, but they do not tell the full story.
Spending 38% of time below range on CGM represents repeated hypoglycemic stress. Even in non‑diabetic patients, frequent time‑below‑range events can provoke counter‑regulatory activation involving cortisol, catecholamines, and glucagon. [2] Over time, this volatility can amplify perceived stress load and impair recovery. It is metabolic instability masquerading as normalcy.
At the same time, triglycerides of 280 mg/dL suggest impaired fatty‑acid handling. In this context, elevated triglycerides often reflect mitochondrial inefficiency rather than simple caloric excess. [3] Energy is present, but it is not being efficiently utilized. The problem is not availability, but it is allocation.
The HPA Axis Context
The clues extend beyond metabolism. Moderate‑to‑high perceived stress, poor recovery from exercise, afternoon fatigue, and motivational flattening raise suspicion for hypothalamic‑pituitary‑adrenal (HPA) axis strain, potentially characterized by low output relative to demand, rather than hyperactivation. [4-6]
Chronic stress does not always present as elevated cortisol. Over time, diurnal amplitude may blunt. [4][5] Patients often feel paradoxically wired yet depleted, experiencing intermittent surges of anxious energy alongside profound fatigue with ordinary tasks. When the HPA axis underperforms relative to demand, downstream axes adjust accordingly. Thyroid signaling may soften, reproductive signaling may shift (night sweats at 42 are not incidental), recovery slows, and the organism prioritizes survival over performance. [1]
Therapeutic Implication: Sequence Matters
Intervention focused on restoring resilience architecture rather than reflexively replacing hormones is essential.
Key elements included:
- Gentle thyroid support for metabolic pacing (without thyroid hormone replacement since thyroid hormone replacement was not medically indicated)
- HPA axis support for suspected low output
- Vitamin D repletion
- Support for shuttling triglycerides into mitochondria
- Frequent moderate physical conditioning rather than high-intensity training
- Hormetic exposures (sauna, contrast showering)
- Modest caloric deficit with higher protein and lower fat than baseline
- Consideration of HPG (hypothalamic-pituitary-gonadal) axis evaluation, if symptoms persisted
- Working with an experienced health coach to empower behavior change and support ease of implementation for these lifestyle recommendations
This distinction matters. Introducing thyroid hormone into a conservation‑dominant phenotype without addressing upstream HPA axis‑mediated strain can transiently increase metabolic demand without expanding resilience capacity. In fragile systems, forcing output often worsens instability.
Twelve-Week Outcome
At follow‑up, the patient demonstrated meaningful clinical improvement:
- 10-pound weight loss
- Resolution of fatigue
- Restoration of motivation (“like her old self”)
- Increased exercise vigor with adequate recovery
- Markedly fewer glycemic excursions on CGM
- Night sweats rare with a reduction in intensity
No thyroid hormone was prescribed and no extreme dietary protocol was required. Once the system no longer perceived the need to conserve so aggressively, expansion followed. The shared decision was made to defer follow-up labs for nine months due to noted improvement and no pharmaceutical intervention.
What If the Numbers Were Different?
Now consider a different scenario: TSH is markedly elevated (e.g., 8–10 mU/L), free T4 remains at 1.0 ng/dL, and free T3 is low. This is no longer simple conservation, but it represents biochemical hypothyroidism. In such cases, exogenous thyroid hormone is reasonable.
However, low free T3 introduces a second question: is conversion impaired? T4‑to‑T3 conversion depends on deiodinase activity, which is influenced by stress, inflammation, micronutrient status, and caloric adequacy. [7-9] Normalizing TSH with T4 alone does not guarantee adequate tissue‑level thyroid signaling. Replacement should be paired with physiologic support, and laboratory normalization should be followed by careful assessment of clinical response.
Clinical Principles Reinforced
Several high‑yield lessons emerge from this case:
- Normal labs do not exclude maladaptive allocation.
- Triglycerides can signal mitochondrial traffic congestion.
- CGM variability can reveal metabolic strain despite normal A1c.
- TSH drift may reflect compensation, not failure.
- Therapeutic sequencing matters. Support resilience before forcing output.
This case is not about autoimmune destruction or glandular failure. It is about adaptive deceleration. Endocrine signaling remains intact, while the system is budgeting conservatively in response to perceived energetic threat. The endocrine network behaves less like isolated silos and more like a coordinated response system. When safety improves, expansion follows. The art lies in knowing when to replace, and when to recognize protection masquerading as pathology.
Disclaimer:
The information provided is for educational purposes only. Consult your physician or healthcare practitioner if you have specific questions before instituting any changes in your daily lifestyle including changes in diet, exercise, and supplement use.
Corey Schuler, PhD, FNP, CNS has dedicated his career to advancing the science and clinical art of integrative medicine and serves as director of medical affairs for Allergy Research Group. He is a family nurse practitioner and practices holistic primary care at Synergy Family Physicians in White Bear Lake, Minnesota.
